Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers

References

• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191–206.
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98:2811–2.
   PubMed Web of Science ®Google Scholar
• Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135–45.
   PubMed Web of Science ®Google Scholar
• Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014;71:785–93.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Mattoo H, Mahajan VS, Deshpande V, Krause D, Song P, et al. IgG4-related midline destructive lesion. Ann Rheum Dis. 2014;73:1434–6.
   PubMed Web of Science ®Google Scholar
• Reder L, Della-Torre E, Stone JH, Mori M, Song P. Clinical manifestations of IgG4-related disease in the pharynx: case series and review of the literature. Ann Otol Rhinol Laryngol. 2015;124:173–8.
   PubMed Web of Science ®Google Scholar
• Inoue A, Wada K, Matsuura K, Osafune H, Ida Y, Kosakai A, et al. IgG4-related disease in the sinonasal cavity accompanied by intranasal structure loss. Auris Nasus Larynx. 2016;43:100–4.
   PubMed Web of Science ®Google Scholar
• Mulholland GB, Jeffery CC, Satija P, Côté DW. Immunoglobulin G4-related diseases in the head and neck: a systematic review. J Otolaryngol Head Neck Surg. 2015;44:24. doi: 10.1186/s40463-015-0071-9.
   PubMed Web of Science ®Google Scholar
• Andrew N, Kearney D, Sladden N, Goss A, Selva D. Immunoglobulin G4-related disease of the hard palate. J Oral Maxillofac Surg. 2014;72:717–23.
   PubMed Web of Science ®Google Scholar
• Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.
   PubMed Web of Science ®Google Scholar
• Creston JE, Dibble PA. Nasal sarcoidosis. Arch Otolaryngol. 1961;74:210–2.
   PubMedGoogle Scholar
• Olsen KD, Neel HB, Deremee RA, Weiland LH. Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Otolaryngol Head Neck Surg (1979). 1980;88:85–9.
   PubMed Web of Science ®Google Scholar
• Trimarchi M, Bussi M, Sinico RA, Meroni P, Specks U. Cocaine-induced midline destructive lesions - an autoimmune disease? Autoimmun Rev. 2013;12:496–500.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.
   PubMed Web of Science ®Google Scholar
• Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:69–87.
   Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
   PubMed Web of Science ®Google Scholar
• Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc. 2015;90:927–39.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14–8.
   PubMed Web of Science ®Google Scholar
• Md Yusof MY, Vital EM, Das S, Dass S, Arumugakani G, Savic S, et al. Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Ann Rheum Dis. 2015;74:1734–8.
   PubMed Web of Science ®Google Scholar
• Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. Advances in human B cell phenotypic profiling. Front Immunol. 2012;3:302. doi: 10.3389/fimmu.2012.00302.
   PubMed Web of Science ®Google Scholar
• Peikert T, Finkielman JD, Hummel AM, McKenney ME, Gregorini G, Trimarchi M, et al. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions. Arthritis Rheum. 2008;58:1546–51.
   PubMed Web of Science ®Google Scholar
• Galperin C, Hoffman GS. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues. Cleve Clin J Med. 1994;61:416–27.
   PubMed Web of Science ®Google Scholar
• Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009;22:589–99.
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.
   PubMed Web of Science ®Google Scholar
• McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg. 2015;31: 167–78.
   PubMed Web of Science ®Google Scholar
• Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International association of pancreatology. Pancreas. 2011;40:352–8.
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236–43.
   PubMed Web of Science ®Google Scholar